Six-ingredient gummy supplying tongkat ali at 200 mg, maca and ashwagandha at 100 mg each and L-arginine at 50 mg, with individual amounts printed rather than grouped into a proprietary blend. Sold in 60-day, 90-day and 180-day configurations with a 60-day satisfaction guarantee.

LAKELAND, FL, August 13, 2026 — HoneyFil is a six-ingredient once-daily gummy dietary supplement for adult men that prints individual milligram amounts for four of its six active ingredients rather than grouping them under a single proprietary blend weight. One of those disclosed amounts, tongkat ali root extract at 200 mg, corresponds to the dose used in the published randomized trials of that ingredient.

That correspondence is unusual in this category and is the reason it leads this announcement. Across multi-ingredient men’s supplements, disclosed amounts commonly fall well below the quantities used in the research that made an ingredient of interest. HoneyFil’s tongkat ali figure does not, and the remaining disclosed amounts do, which this release sets out ingredient by ingredient below.

The product is taken as one gummy daily and is sold direct to consumers online, with order processing handled by a third-party cart platform. It is available in two-bottle, three-bottle and six-bottle configurations.

Product information and current package options are published at the HoneyFil official website (affiliate link, see disclosure below).

Product Overview

The disclosure format carries a regulatory dimension. Under 21 CFR 101.36, U.S. manufacturers may group ingredients into a proprietary blend and declare only the combined weight, without stating how much of any single component is present. The practice is legal and widespread, and it is the reason many supplement panels cannot be compared against published research. HoneyFil uses that provision for two of its six ingredients and not for the other four.

The four ingredients with stated amounts are tongkat ali extract (Eurycoma longifolia) at 200 mg, maca root extract at 100 mg, ashwagandha extract at 100 mg, and L-arginine HCl at 50 mg. Two further ingredients are named without amounts: Epimedium sagittatum extract, and a combination of beet root and grape seed extract. The published listing gives no extraction ratio or standardisation percentage for any of the six.

The product is taken as one gummy daily. The company describes it as gluten-free, non-GMO, and manufactured in the United States in a GMP-certified, FDA-registered facility. Registration of a facility with the FDA is an administrative filing requirement. It is not FDA approval of the product, and it does not indicate that any claim about the product has been reviewed.

Statement from the Company

“We print the amounts for most of what is in this product because a buyer cannot evaluate a formula they cannot see. We should be equally clear about the limits of that. Two ingredients on our list do not carry stated amounts, and we do not publish a standardisation figure for our tongkat ali extract, which means a buyer cannot independently confirm the concentration of the active compounds in it. Extract quality varies across this ingredient and that variation is real. Anyone taking prescription medication, and particularly anyone on nitrate medication, should speak with their clinician before adding this or any botanical supplement.”

— Kevin Mat., Media Relations, HoneyFil

Ingredient Research: The Four Disclosed Amounts

This section examines the four ingredients carrying stated amounts, placing each figure beside the doses used in published research. The two ingredients without stated amounts cannot be examined this way, and their omission here reflects that absence rather than any judgement about them.

Important qualification: all citations below describe research unaffiliated with HoneyFil, in several cases at doses substantially above the amounts on this label, and where that is so it is stated alongside the citation. These citations establish that these ingredients have been studied. They are not clinical evidence that HoneyFil produces equivalent outcomes, and no such equivalence is claimed.

Tongkat ali extract (Eurycoma longifolia), 200 mg. A root extract used traditionally across Southeast Asia and the most extensively trialled ingredient in this formula. A double-blind, placebo-controlled study published in the Journal of the International Society of Sports Nutrition (Talbott, S.M., et al., 2013, 10:28) supplemented 63 moderately stressed adults with 200 mg daily of a standardised root extract for four weeks and reported approximately 16 percent lower salivary cortisol together with improvements in tension, anger and confusion scores. A systematic review and meta-analysis published in Medicina (Leisegang, K., et al., 2022, 58(8):1047, doi:10.3390/medicina58081047) pooled five randomised trials and reported a significant increase in total testosterone (SMD 1.352, 95% CI 0.565 to 2.138, p = 0.001), with the clearest effects in men with hypogonadism or age-related decline and more modest, less consistent effects in younger men with normal baseline levels. Clinical protocols for this ingredient converge on 200 to 400 mg daily. The amount here sits at the lower end of that range rather than below it.

A note on standardisation. The trials above used specific standardised preparations. The Talbott study used an extract standardised to 22 percent eurypeptides and 40 percent glycosaponins; other trials used a freeze-dried aqueous extract, and clinical guidance commonly specifies 1 to 2 percent eurycomanone content. Tongkat ali extracts vary substantially in active compound concentration, and an extraction ratio alone does not indicate that concentration. HoneyFil’s published listing does not state a standardisation. The disclosed 200 mg therefore matches the studied dose by weight, and whether it matches by active content cannot be determined from the information published. This is the single most useful question a prospective buyer can put to the company.

Ashwagandha extract, 100 mg. An adaptogen studied for stress-related endpoints. A systematic review and meta-analysis published in Nutrition and Health (Albalawi, A.A., 2025, 31(4):1395–1408) covering 488 participants reported an average cortisol reduction of 1.16 µg/dL while finding no significant pooled improvement in perceived stress. The NIH Office of Dietary Supplements cites a provisional expert recommendation of 300 to 600 mg daily of standardised root extract (Ashwagandha Fact Sheet, NIH ODS; ods.od.nih.gov). The 100 mg here is approximately one third of the lower bound of that range.

Maca root extract, 100 mg. A Peruvian root crop with documented traditional use as a food. A systematic review published in BMC Complementary and Alternative Medicine (Shin, B.C., et al., 2010, 10:44) identified four randomised trials covering 131 participants at daily doses of 1.5 to 3.5 grams and judged the available evidence insufficient to draw firm conclusions. The 100 mg here is between one fifteenth and one thirty-fifth of the doses used in those trials.

L-arginine HCl, 50 mg. An amino acid the body uses as a substrate for nitric oxide synthesis. A meta-analysis published in the American Journal of Clinical Nutrition (Bai, Y., et al., 2009, 89(1):77–84) reported improved flow-mediated dilation following short-term oral L-arginine, with the effect confined to participants whose baseline values were low. Human L-arginine interventions are measured in grams rather than milligrams, commonly 1.5 to 5 grams daily. The 50 mg here is approximately one thirtieth of the lower end of that range.

What the Disclosed Amounts Show

Disclosure benefits a buyer only when the figures are placed beside those used in research, so that comparison is made above rather than implied. It produces a split result. Tongkat ali is supplied at the dose used in published trials, subject to the standardisation question set out above. Ashwagandha is supplied at roughly a third of the low end of its studied range, maca at between one fifteenth and one thirty-fifth, and L-arginine at approximately one thirtieth. Two ingredients carry no stated amount and cannot be assessed.

The published findings themselves are mixed and are reported here as the authors stated them. The ashwagandha meta-analysis found no significant pooled improvement in perceived stress while reporting a cortisol reduction. The maca review judged its evidence base insufficient for firm conclusions. The L-arginine meta-analysis found an effect only in participants with low baseline vascular function. The tongkat ali meta-analysis reported its clearest effects in men with hypogonadism rather than in the general adult population.

Ingredient research is a reason to examine a formula. It is not a substitute for testing the formula itself, and no published clinical trial has evaluated HoneyFil as sold.

Format and Daily Use

HoneyFil is positioned as an addition to an established routine rather than a replacement for one. The company’s stated support areas are circulation, daily energy and general male well-being, and it recommends consistent daily use for at least 30 to 90 days before assessing the product. Sleep, physical activity, dietary pattern and medical history remain the principal determinants of energy and general health.

Anyone with a diagnosed condition, or experiencing persistent fatigue or reduced physical capacity, should seek evaluation from a licensed clinician rather than relying on a dietary supplement. Those symptoms are frequently the first presenting sign of conditions including cardiovascular disease, type 2 diabetes and thyroid disorders, none of which a supplement identifies or addresses.

Market Context

The figures below are third-party industry context for the category and are not claims by HoneyFil about its own commercial performance.

The global men’s health supplements market was valued at approximately $75.09 billion in 2024 and is projected to reach $132.13 billion by 2030, at a compound annual growth rate of 10.07 percent, according to Grand View Research (Men’s Health Supplements Market Size, Share and Trends Analysis Report, Grand View Research, 2025; grandviewresearch.com). That assessment reported weight management supplements as the largest product segment at 36.16 percent of the market in 2024, and men aged 31 to 45 as the largest age segment at 30.53 percent.

A separate assessment placed the category at approximately $59.5 billion in 2025, rising to $137.91 billion by 2035 at a compound annual growth rate of 8.77 percent, according to SNS Insider (Men’s Health Supplements Market Report, SNS Insider, 2026; snsinsider.com). The same firm valued the U.S. portion of that market at approximately $9.8 billion in 2025.

The two baseline figures differ by roughly 20 percent, reflecting differing category definitions rather than a dispute about the underlying commerce. Both are given because quoting either alone would suggest a precision the category does not have.

Availability and Pricing

HoneyFil is sold through the brand’s official website, with checkout handled by a third-party cart platform. Three package configurations are listed at the time of this release:

  • Two bottles, a 60-day supply, at $79 per bottle, $158 total

  • Three bottles, a 90-day supply, at $69 per bottle, $207 total, with free shipping

  • Six bottles, a 180-day supply, at $49 per bottle, $294 total, with free shipping

No single-bottle configuration is offered. The company states that orders are processed within 24 to 48 hours and that delivery typically takes 3 to 10 business days depending on location. Pricing and promotional terms are set by the seller and subject to change; the checkout total is the operative figure, and buyers should confirm current terms there rather than relying on any third-party description, including this one.

Every order is covered by a 60-day satisfaction guarantee, measured from the original purchase date rather than from delivery. Because shipping is quoted at 3 to 10 business days, that transit time falls inside the guarantee window, and buyers should diarise the expiry date from the purchase date accordingly. Refund requests are initiated through the company’s contact page. The company’s published information also indicates that an optional subscription may be offered at checkout, so buyers who intend a one-time purchase should confirm the order summary before paying.

Current package options, pricing and guarantee terms are listed at the HoneyFil official website.

Quality and Manufacturing

The company states that HoneyFil is manufactured and packaged in the United States in a GMP-certified, FDA-registered facility, and describes the product as gluten-free and non-GMO. It states a shelf life of 24 months from the manufacturing date printed on each bottle, with storage in a cool, dry place.

The published product pages reviewed for this release do not name a distributing company or corporate entity, do not identify the manufacturing facility, and do not publish a certificate of analysis or third-party testing record. This describes the available documentation rather than criticising it. Under 21 CFR Part 111, dietary supplement manufacturers must comply with current Good Manufacturing Practice regulations covering production standards, ingredient identity testing, quality control and accurate labeling, whether or not a claim to that effect appears on a label. Buyers wanting manufacturing records, batch testing results or an extract standardisation figure should request them from the seller directly.

Usage Guidance and Safety Information

HoneyFil is intended for adult use. The label directs users to take one gummy daily, preferably at the same time each day, and not to exceed the recommended dose.

One interaction warrants particular attention. Epimedium sagittatum contains icariin, which has shown blood-vessel-dilating activity in laboratory research. Anyone taking nitrate medication for angina or another cardiac condition, including nitroglycerin in any form such as as-needed sprays or patches, should consult their prescriber before using this or any product containing Epimedium, because combining nitrate medication with vasodilating compounds can produce a dangerous fall in blood pressure. The absence of a stated amount for this ingredient makes that conversation more important rather than less.

Tongkat ali carries several considerations relevant to daily use. It may accelerate hair shedding in men predisposed to androgenic alopecia. It has demonstrated mild insulin-sensitising properties, so fasted use alongside a substantial calorie deficit may cause transient gastrointestinal upset or low blood sugar in sensitive individuals. It can have a mild stimulatory effect, making evening dosing less suitable for anyone prone to insomnia. Men with hormone-sensitive conditions, or receiving hormone therapy, should consult a clinician before use.

Ashwagandha may interact with thyroid, diabetes, blood pressure, sedative and immunosuppressant medications, and has been associated with liver injury in published case reports. Anyone taking medication affecting blood pressure or blood glucose should treat the presence of L-arginine and tongkat ali in this formula as a reason to consult a prescriber, not a reason to substitute.

The product is not intended for anyone under 18. Individual results vary. This product is not a substitute for professional medical care and is not a treatment for any medical condition.

Scope of This Announcement

This is a product availability announcement, not a clinical trial report, an efficacy claim or an independent evaluation. No product testing was conducted for it, no units were independently assayed, and no outside experts were interviewed. The research referenced concerns individual ingredients rather than the assembled product.

Three points bear on any evaluation. Three of the four disclosed amounts fall below the doses used in the research cited, stated ingredient by ingredient above. The fourth matches by weight, while the absence of a published standardisation figure leaves its active content undetermined. And two of the six ingredients carry no stated amount, so no comparison against research is possible for them.

Disclosures

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. It is a dietary supplement and is not a substitute for medical advice, diagnosis, prescribed medication or treatment of any condition, and individual results may vary. Consult a qualified healthcare professional before use.

This press release contains a link to a retail partner website through which the distributor may receive compensation if a purchase is made following a referral, disclosed in accordance with the Federal Trade Commission’s guidelines on endorsements and testimonials (16 CFR Part 255). The affiliate relationship does not influence the factual content of this release. No compensation was provided to any researcher, journal or institution cited above, and no citation should be read as an endorsement of this product by its authors or publisher.

About HoneyFil

HoneyFil is a men’s daily wellness gummy supplement containing tongkat ali extract at 200 mg, maca root extract at 100 mg, ashwagandha extract at 100 mg and L-arginine HCl at 50 mg, together with Epimedium sagittatum extract and a beet root and grape seed extract combination. Individual amounts are disclosed for four of the six ingredients. The product is taken as one gummy daily, is described by the company as gluten-free, non-GMO and manufactured in the United States in a GMP-certified, FDA-registered facility, and is sold direct to consumers with a 60-day satisfaction guarantee. HoneyFil is a dietary supplement and is not intended to diagnose, treat, cure or prevent any disease.

Media Contact

Kevin Matthews, Media Relations Manager

HoneyFil

Customer support (SMS): +1 866-541-2939

Email: support@honeyfil.store, support@cartpanda.com

Website: https://honeyfil.store/

Address: 9655 E 35th Drive, Suite 100, Aurora, CO 80011 — USA

Multimedia Assets

Product bottle images, the Supplement Facts panel and brand logo files are available on request from the media contact above.

References

Talbott SM, Talbott JA, George A, Pugh M. Effect of Tongkat Ali on stress hormones and psychological mood state in moderately stressed subjects. J Int Soc Sports Nutr. 2013;10:28.

Leisegang K, Finelli R, Sikka SC, Panner Selvam MK. Eurycoma longifolia (Jack) improves serum total testosterone in men: a systematic review and meta-analysis of clinical trials. Medicina (Kaunas). 2022;58(8):1047. doi:10.3390/medicina58081047

Albalawi AA. Dual impact of ashwagandha: significant cortisol reduction but no effects on perceived stress — a systematic review and meta-analysis. Nutrition and Health. 2025;31(4):1395–1408.

National Institutes of Health, Office of Dietary Supplements. Ashwagandha: Is it helpful for stress, anxiety, or sleep? Health Professional Fact Sheet.

Shin BC, Lee MS, Yang EJ, Lim HS, Ernst E. Maca (L. meyenii) for improving health function: a systematic review. BMC Complement Altern Med. 2010;10:44.

Bai Y, Sun L, Yang T, Sun K, Chen J, Hui R. Increase in fasting vascular endothelial function after short-term oral L-arginine is effective when baseline flow-mediated dilation is low. Am J Clin Nutr. 2009;89(1):77–84.

Grand View Research. Men’s Health Supplements Market Size, Share and Trends Analysis Report, 2025–2030.

SNS Insider. Men’s Health Supplements Market Report, 2026–2035.

For more press release distribution and guest post services, visit TS Newswire.

Media gallery

About The Author
TS NEWSWIRE